These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33609521)

  • 1. Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug.
    Mamidi HK; Rohera BD
    J Pharm Sci; 2021 Jul; 110(7):2703-2717. PubMed ID: 33609521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).
    Hu Z; Xu P; Ashour EA; Repka MA
    AAPS PharmSciTech; 2022 Jun; 23(6):169. PubMed ID: 35715519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical and experimental validation of praziquantel with different polymers for selection of an appropriate matrix for hot-melt extrusion.
    Bhatt U; Suryanarayana Murty U; Banerjee S
    Int J Pharm; 2021 Sep; 607():120964. PubMed ID: 34339813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.
    Li S; Tian Y; Jones DS; Andrews GP
    AAPS PharmSciTech; 2016 Feb; 17(1):200-13. PubMed ID: 26729536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
    Marsac PJ; Li T; Taylor LS
    Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
    Piccinni P; Tian Y; McNaughton A; Fraser J; Brown S; Jones DS; Li S; Andrews GP
    J Pharm Pharmacol; 2016 May; 68(5):705-20. PubMed ID: 26864155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016; 42(3):446-55. PubMed ID: 26289001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.
    Donnelly C; Tian Y; Potter C; Jones DS; Andrews GP
    Pharm Res; 2015 Jan; 32(1):167-79. PubMed ID: 25074468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
    Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory.
    Bansal K; Baghel US; Thakral S
    AAPS PharmSciTech; 2016 Apr; 17(2):318-27. PubMed ID: 26092302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
    Djuris J; Nikolakakis I; Ibric S; Djuric Z; Kachrimanis K
    Eur J Pharm Biopharm; 2013 May; 84(1):228-37. PubMed ID: 23333900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of pharmaceutical cocrystal formulations via melt mixing technique: A thermodynamic perspective.
    Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K
    Eur J Pharm Biopharm; 2018 Oct; 131():130-140. PubMed ID: 30092346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
    Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
    Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Method of Constructing a Drug-Polymer Temperature-Composition Phase Diagram Using Hot-Melt Extrusion.
    Tian Y; Jones DS; Donnelly C; Brannigan T; Li S; Andrews GP
    Mol Pharm; 2018 Apr; 15(4):1379-1391. PubMed ID: 29205040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphous Solid Dispersions of Felodipine and Nifedipine with Soluplus®: Drug-Polymer Miscibility and Intermolecular Interactions.
    Sarpal K; Munson EJ
    J Pharm Sci; 2021 Apr; 110(4):1457-1469. PubMed ID: 33359813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.